TCL Archive Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease August 30, 2013
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
TCL Archive Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says. December 9, 2005
TCL Archive BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women November 3, 1978